Example: Heart Attack

Clinical Trials on Breast Cancer

Total 10934 results

NCT05880927

Recruiting

Pyrotinib After Trastuzumab-based Adjuvant Therapy in Patients With HER2-positive Breast Cancer

Breast Cancer
NCT05880394

Recruiting

Rayzebio IIT Study of Dotatate in Breast Cancer

Breast Cancer Stage IV
NCT05878964

Not yet recruiting

Evaluation of Skin Health and Quality of Life in Patients Receiving Anti-PD1/PDL1/CTLA4 or Cyclin-dependent Kinase (CDK) Inhibitors. (SkinHealthOnco)

Melanoma Kidney Cancer Breast Cancer Gastric Cancer Lung Cancer Bladder Cancer Skin Cancer Head Neck Cancer
NCT05879926

Not yet recruiting

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)

Breast Cancer
NCT05880160

Not yet recruiting

Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction (HER-SAFE)

Heart Failure HER2-positive Breast Cancer Cardiotoxicity Cancer, Therapy-Related
NCT05877599

Not yet recruiting

A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Breast Cancer Pancreatic Adenocarcinoma Non-small Cell Lung Cancer Head and Neck Squamous Cell Carcinoma Colorectal Carcinoma Other Solid Tumors
NCT05878678

Recruiting

Prospective Study of Particle Radiotherapy for Breast Cancer With Different Arm Position

Breast Cancer
NCT05878106

Not yet recruiting

Creatine Supplementation and Resistance Training in Patients With Breast Cancer (CaRTiC)

Quality of Life Breast Cancer Supplementation Resistance Training Physical Performance
NCT05877859

Not yet recruiting

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

Breast Cancer Stage II Breast Cancer Stage III Breast Cancer Invasive Breast Cancer Triple Negative
NCT05878314

Recruiting

Impact of Endocrine Therapy, Menstrual Cycle, PAM50, Ki67 on Treatment Decisions in HR+ and HER2- Breast Cancer

Hormone Receptor Positive HER-2 Negative Breast Cancer
NCT05876728

Not yet recruiting

Role of Irisin/FNDC5 (rs3480) Single Nucleotide Polymorphism in Breast Cancer

Breast Cancer
NCT05876065

Not yet recruiting

Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast Cancer

Advanced Breast Cancer
NCT05874492

Not yet recruiting

Evaluation of the Medical Benefit of Spa Therapy on Fibrosis After Postoperative Radiotherapy for Breast Cancer (FIBROTHERME)

Fibrosis Breast Cancer
NCT05873036

Recruiting

Comparison of AT & PR Training to Improve Functional Ability After Breast Cancer Surgery

Breast Cancer
NCT05873296

Recruiting

Health Education for Women With Breast Cancer

Breast Cancer Female
NCT05872412

Not yet recruiting

Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer

Triple Negative Breast Cancer
NCT05872347

Not yet recruiting

Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.

Breast Cancer Brain Metastases
NCT05872295

Not yet recruiting

IKS014 in Advanced Solid Tumors That Express HER2

Breast Cancer Gastric Cancer Gastroesophageal-junction Cancer
NCT05874297

Not yet recruiting

Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer (ONE)

Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8
NCT05870813

Recruiting

CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective Registry - Breast Cancer (CLEAR-B)

Breast Cancer Hormone Receptor Positive Breast Carcinoma HER2-negative Breast Cancer
NCT05871918

Recruiting

A Multicenter, Randomized, Open, Phase III Trial of ddEC-THPvs Evaluating the Efficacy and Safety of TCHP Neoadjuvant Therapy for HER2-positive Breast Cancer

HER-2 Positive Breast Cancer
NCT05871125

Not yet recruiting

Identifying Ideal Reimbursement "Dose" to Reduce Clinical Trial-related Financial Toxicity

Breast Cancer
NCT05871008

Not yet recruiting

Integrated Actionable Aging Assessment for Cancer Patients Pilot

Kidney Cancer Leukemia Myeloid Leukemia Breast Cancer Multiple Myeloma Hodgkin Lymphoma Prostate Cancer Bladder Cancer Lymphoid Leukemia Monocytic Leukemia
NCT05871437

Not yet recruiting

Huaier Granule on Reducing the Level of Tumor Markers in Patients With Early-stage Breast Cancer

Early-stage Breast Cancer
NCT05870579

Not yet recruiting

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2-, GRPR+ Breast Cancer

Breast Cancer
NCT05870241

Not yet recruiting

Post-Mastectomy Shoulder Pain And Lymphedema Responses To Ga-As Laser Versus Microcurrent Electrical Stimulation (PM)

Post Mastectomy Lymphedema
NCT05868746

Not yet recruiting

An Observational Pilot Study to Test a Smartwatch-based EMA Method During Exercise With Breast Cancer Survivors

Breast Cancer
NCT05867966

Not yet recruiting

Psychoneurological Symptom Cluster in Oncology

Cancer Breast Cancer Digestive Cancer
NCT05867667

Not yet recruiting

Cardiac Rehabilitation to Improve Breast Cancer Outcomes (CRIBCO)

Cardiovascular Diseases Breast Cancer
NCT05868226

Recruiting

PRE-I-SPY Phase I/Ib Oncology Platform Program (PRE-I-SPY-PI)

Solid Tumor Metastatic Cancer Metastatic Breast Cancer Triple Negative Breast Cancer HER2-positive Breast Cancer Solid Tumor, Adult Solid Carcinoma HER2-positive Metastatic Breast Cancer Progesterone Receptor-positive Breast Cancer HER2-negative Breast Cancer
NCT05866432

Recruiting

Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases (TUXEDO-2)

Breast Cancer Stage IV
NCT05866458

Not yet recruiting

Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy (ROSALIE)

Breast Cancer
NCT05865990

Not yet recruiting

HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease (TUXEDO-3)

Metastatic Breast Cancer Solid Tumor, Adult Advanced Non-Small Cell Squamous Lung Cancer
NCT05864144

Recruiting

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Melanoma Sarcoma Kidney Cancer Breast Cancer Head and Neck Cancer Gastric Cancer Pancreatic Cancer Esophageal Cancer Ovarian Cancer Prostate Cancer
NCT05861635

Recruiting

The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression

Breast Cancer Neoadjuvant Therapy

Clinical Trials on Breast Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations